HQP1351

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

LeukemiaMyeloid Leukemia

508 competitors in Leukemia

#DrugCompanyPhaseTrials

1

Cytosar

Teva

Phase 3

512

Trexall

Alnylam Pharmaceuticals

Phase 3

313

Fludara

Sanofi

Phase 3

224

Rituxan

Roche

Phase 3

165

Idamycin

Pfizer

Phase 3

106

Vepesid

AAvyxa

Phase 3

257

Neoral

Novartis

Phase 3

98

Decadron

AAspen Global Incorporated

Phase 3

249

Cellcept

Roche

Phase 3

610

Oncovin

EEastern Cooperative Oncology Group

Phase 3

15Show 36 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Myeloid Leukemia4 trials

A Pivotal Study of HQP1351 in Patients of Chronic Myeloid Leukemia in Accelerated Phase With T315I Mutation

Unknown status·Ascentage Pharma Group Inc.·Phase 2·NCT03883100·23 enrolled

A Pivotal Study of HQP1351 in Patients With Chronic Myeloid Leukemia in Chronic Phase

Completed·Ascentage Pharma Group Inc.·Phase 2·NCT04126681·144 enrolled

A Pivotal Study of HQP1351 in Patients of Chronic Myeloid Leukemia in Chronic Phase With T315I Mutation

Unknown status·Ascentage Pharma Group Inc.·Phase 2·NCT03883087·41 enrolled

Show 1 more trial

Pharmacokinetics Profiles of HQP1351 Under Fasting and High-fat Meals in Patients With Chronic Myeloid Leukemia

Completed·Ascentage Pharma Group Inc.·Phase 1·NCT03882281·12 enrolled

Other Solid Tumors1 trial

A Study of HQP1351 in Patients With GIST or Other Solid Tumors

Recruiting·Ascentage Pharma Group Inc.·Phase 1·NCT03594422·100 enrolled

Leukemia1 trial

Prophylactic HQP1351 Therapy Post-transplants on Leukemia After Allo-HSCT

Withdrawn·Xxuna·Phase 2·NCT05604755

Absorption1 trial

The Absorption, Metabolism and Excretion of [14C] HQP1351 in Humans

Completed·Ascentage Pharma Group Inc.·Phase 1·NCT04126707·6 enrolled

Details

Drug Info

Related News